Market Tracker

09/17 1:34pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

355.06
Data as of 1:19pm ET
 -0.41 / -0.12%
Today’s Change
257.69
Today|||52-Week Range
369.31
+29.00%
Year-to-Date

Today’s Trading

Previous close355.47
Today’s open357.30
Day’s range354.29 - 360.50
Volume266,423
Average volume (3 months)859,604
Market cap$35.9B
Dividend yield--
Data as of 1:19pm ET, 09/17/2014

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)+25.02%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+52.69%
P/E ratio98.9
Price/Sales12.80
Price/Book18.15

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.77-1.35%
ALNYAlnylam Pharmaceutic...+2.96+4.03%
CBSTCubist Pharmaceutica...-0.21-0.31%
ISISIsis Pharmaceuticals...+1.09+2.76%
Data as of 1:33pm ET, 09/17/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$2.56
Annual revenue (last year)$2.1B
Annual profit (last year)$424.4M
Net profit margin20.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts